WallStreetZenWallStreetZen

NASDAQ: GCTK
Glucotrack Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

GCTK past revenue growth

How has GCTK's revenue growth performed historically?
Company
N/A
Industry
8.04%
Market
16.81%
GCTK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
GCTK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

GCTK earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$7.1M
Current Profit Margin
0%

GCTK Return on Equity

Current Company
-172%
Current Industry
11.1%
Current Market
188%
GCTK's Return on Equity (-172%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when GCTK announces earnings.

GCTK Return on Assets

Current Company
-127.1%
Current Industry
7.2%
GCTK is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

GCTK Return on Capital Employed

Current Company
-209.37%
Current Industry
9.7%
GCTK's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GCTK vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
GCTK$0.00-$7.09M-$7.10M-100.00%N/A
NEPH$14.24M-$1.36M-$1.58M+20.15%N/A
EKSO$17.91M-$12.30M-$14.24M+7.58%N/A
MHUA$97.10M$15.80M$11.63M+5.08%-12.34%
MBOT$0.00-$10.63M-$10.74MN/AN/A
View Top Medical Stocks

Glucotrack Earnings & Revenue FAQ

What were GCTK's earnings last quarter?

Glucotrack (NASDAQ: GCTK) reported Q4 2023 earnings per share (EPS) of -$0.10, up 11.11% year over year. Total Glucotrack earnings for the quarter were -$2.41 million. In the same quarter last year, Glucotrack's earnings per share (EPS) was -$0.09.

If you're new to stock investing, here's how to buy Glucotrack stock.

What was GCTK's earnings growth in the past year?

As of Q2 2024, Glucotrack's earnings has grown year over year. Glucotrack's earnings in the past year totalled -$7.10 million.

What was GCTK's revenue last quarter?

Glucotrack (NASDAQ: GCTK) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Glucotrack's revenue was $0.00.

What was GCTK's revenue growth in the past year?

As of Q2 2024, Glucotrack's revenue has grown null year over year. Glucotrack's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.